NeuPath Health Inc. (NPTH.V)

0.1650 0.0000 (0.00%) At close: 01:54PM EDT

NeuPath Health Inc.

6400 Millcreek Drive
Unit 9
Mississauga, ON L5N 3E7
Canada
905 858 1368
https://www.neupath.com

Sector(s): Healthcare
Industry: Medical Care Facilities
Full Time Employees: 156

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Joseph Andrew Walewicz MBA	CEO & Director	514.44k	N/A	1969
Mr. Jeff Zygouras C.A., CPA	CFO & Corporate Secretary	427k	N/A	N/A
Bjorn Thies	Vice President of People & Culture	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

NeuPath Health Inc. provides chronic pain management services in Canada. The company offers chronic pain assessment and multi-modal treatment plan that helps patient to manage pain and optimize quality of life. It also provides workplace health services and independent medical assessments to employers and disability insurers through a national network of health care providers comprising cardiologists, dentists, dermatologists, endocrinologists, psychiatrists, gastroenterologists, general practitioners, internal medicine specialists, neurologists, neuropsychiatrists, neuropsychologists, occupational therapists, ophthalmologists, orthopedic surgeons, physiatrists, physiotherapists, psychologists, respirologists, and rheumatologists. In addition, the company operates a network of healthcare clinics and related businesses. The company is headquartered in Mississauga, Canada.

Corporate Governance

NeuPath Health Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.